SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 10.46 |
Enterprise Value ($M) | 7.46 |
Book Value ($M) | 4.51 |
Book Value / Share | 0.23 |
Price / Book | 2.32 |
NCAV ($M) | -1.95 |
NCAV / Share | -0.10 |
Price / NCAV | -5.35 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.69 |
Return on Assets (ROA) | -0.66 |
Return on Equity (ROE) | -5.07 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.74 |
Current Ratio | 1.05 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 19.76 |
Assets | 26.23 |
Liabilities | 21.72 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 59.51 |
Operating Income | -13.21 |
Net Income | -15.91 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -5.03 |
Cash from Investing | 0.20 |
Cash from Financing | 6.49 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Empery Asset Management, LP | 5.36 | ||
13D/A | Starke Clifford | 19.10 | 30.80 | |
13D/A | Vaiman Dany | 5.60 | 52.80 | |
13G/A | Global X Management CO LLC | 0.00 | -100.00 | |
13G | Rds Private Capital Ii, Lp | 9.79 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
8,218 | 35,004 | 23.48 | |
28,641 | 101,263 | 28.28 | |
121,819 | 254,510 | 47.86 | |
(click for more detail) |
Similar Companies | |
---|---|
FBLG – FibroBiologics, Inc. | FBRX – Forte Biosciences, Inc. |
FENC – Fennec Pharmaceuticals Inc. | FTLF – FitLife Brands, Inc. |
GALT – Galectin Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io